Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Acta Physiologica (Oxford, England)
|
May 24, 2023
Engineering bacteria to modulate host metabolism
Dragos Ciocan, Eran Elinav
Gut
|
March 10, 2023
New insights into an old paradigm: why IgA accumulates in alcoholic liver disease and what could be its role
Dragos Ciocan, Williams Turpin
Medecine Sciences : M/S
|
May 2, 2020
[Intestinal bacteria involved in nutritional liver disease killed by phagotherapy: a new therapeutic target]
Dragos Ciocan, Anne-Marie Cassard
Ebiomedicine
|
May 31, 2022
In the quest for treating alcohol liver disease
Dragos Ciocan, Anne-Marie Cassard
Clinical and Molecular Hepatology
|
December 23, 2017
Microbiota, a key player in alcoholic liver disease
Anne-Marie Cassard, Dragos Ciocan
Nutrients
|
January 8, 2023
Pectin in Metabolic Liver Disease
Wanchao Hu, Anne-Marie Cassard, Dragos Ciocan
Nature Reviews. Microbiology
|
December 19, 2023
Utilization of the microbiome in personalized medicine
Karina Ratiner, Dragos Ciocan, Suhaib K Abdeen, et al.
Soins. Gerontologie
|
August 20, 2013
[Coordination in emergency departments by a mobile geriatrics unit]
Elodie Crétel, Dragos Ciocan, Catherine Molines, et al.
Scientific Reports
|
March 16, 2021
Specific microbiome profile in Takayasu's arteritis and giant cell arteritis
Anne Claire Desbois, Dragos Ciocan, David Saadoun, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
October 16, 2010
Endogenous adenosine A1 receptor activation underlies the transient post-ischemic rhythmic delta EEG activity
Alexandra Oana Constantinescu, Andrei Ilie, Dragos Ciocan, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Acta Physiologica (Oxford, England)
|
May 24, 2023
Engineering bacteria to modulate host metabolism
Dragos Ciocan, Eran Elinav
Gut
|
March 10, 2023
New insights into an old paradigm: why IgA accumulates in alcoholic liver disease and what could be its role
Dragos Ciocan, Williams Turpin
Medecine Sciences : M/S
|
May 2, 2020
[Intestinal bacteria involved in nutritional liver disease killed by phagotherapy: a new therapeutic target]
Dragos Ciocan, Anne-Marie Cassard
Ebiomedicine
|
May 31, 2022
In the quest for treating alcohol liver disease
Dragos Ciocan, Anne-Marie Cassard
Clinical and Molecular Hepatology
|
December 23, 2017
Microbiota, a key player in alcoholic liver disease
Anne-Marie Cassard, Dragos Ciocan
Nutrients
|
January 8, 2023
Pectin in Metabolic Liver Disease
Wanchao Hu, Anne-Marie Cassard, Dragos Ciocan
Nature Reviews. Microbiology
|
December 19, 2023
Utilization of the microbiome in personalized medicine
Karina Ratiner, Dragos Ciocan, Suhaib K Abdeen, et al.
Soins. Gerontologie
|
August 20, 2013
[Coordination in emergency departments by a mobile geriatrics unit]
Elodie Crétel, Dragos Ciocan, Catherine Molines, et al.
Scientific Reports
|
March 16, 2021
Specific microbiome profile in Takayasu's arteritis and giant cell arteritis
Anne Claire Desbois, Dragos Ciocan, David Saadoun, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
October 16, 2010
Endogenous adenosine A1 receptor activation underlies the transient post-ischemic rhythmic delta EEG activity
Alexandra Oana Constantinescu, Andrei Ilie, Dragos Ciocan, et al.
Page
of 4